How Epigenetics Works: Gene Expression, DNA Methylation, and Heritable Changes

Beyond the DNA Sequence

For most of the 20th century, the central focus of genetics was the DNA sequence — the four-letter code (A, T, G, C) that specifies proteins and determines biological function. But a profound puzzle persisted: every cell in the human body contains essentially the same DNA sequence. A liver cell and a neuron in the same person have identical genomes. Yet they are radically different in form and function. How does the same genetic information produce such diverse cell types?

The answer lies in epigenetics — literally "above genetics" — the study of heritable changes in gene activity that do not involve changes to the underlying DNA sequence. Epigenetic mechanisms determine which genes are turned on or off in each cell type, creating the diversity of the 200+ cell types in the human body from a single set of genetic instructions.

What Epigenetic Mechanisms Do

Epigenetic regulation operates primarily through two molecular systems that control the physical accessibility of DNA to the transcription machinery:

1. DNA Methylation

DNA methylation is the addition of a methyl group (–CH₃) to the cytosine base of DNA, predominantly at CpG dinucleotides (cytosine followed by guanine). This modification is carried out by enzymes called DNA methyltransferases (DNMTs). Methylation of gene promoter regions is generally associated with transcriptional silencing — the gene is turned off.

CpG islands — regions of the genome with clusters of CpG dinucleotides — are particularly important in gene regulation. Roughly 70% of human gene promoters overlap with CpG islands. In normal cells, most CpG islands are unmethylated (allowing expression of housekeeping genes), while CpG sites in other genomic regions (including transposons and repetitive elements) are heavily methylated to maintain genome stability.

Abnormal methylation is a hallmark of cancer: tumor suppressor gene promoters are often hypermethylated (silenced) in cancer cells, while repetitive elements become hypomethylated (potentially destabilizing).

2. Histone Modification

DNA in the nucleus is not free — it is wrapped around protein spools called histones, forming chromatin. The degree to which DNA is compacted determines its accessibility for transcription. Histones are modified by enzymes that add or remove chemical marks to their tails:

• Histone acetylation (by HATs/HDACs): Acetylation of lysine residues neutralizes the positive charge of histones, reducing their interaction with negatively charged DNA and opening chromatin — generally associated with active gene expression
• Histone methylation (by HMTs): Can either activate or repress transcription depending on which residue is methylated and the degree of methylation (mono-, di-, or tri-methylation)
• Histone phosphorylation: Associated with DNA repair and mitosis regulation
• Ubiquitination: Involved in both activation and repression depending on target residue

These histone marks constitute a histone code — a combinatorial language that recruits specific regulatory proteins to control transcription, DNA repair, and replication.

Non-Coding RNA in Epigenetics

A third layer of epigenetic regulation involves non-coding RNA molecules:

• MicroRNAs (miRNAs): ~22-nucleotide RNA molecules that bind complementary mRNA sequences, inhibiting translation or causing mRNA degradation. Over 2,000 miRNAs have been identified in humans, regulating ~60% of protein-coding genes.
• Long non-coding RNAs (lncRNAs): >200-nucleotide transcripts that recruit chromatin-modifying complexes to specific genomic locations. XIST, the lncRNA responsible for X-chromosome inactivation in females, coats one X chromosome and recruits the Polycomb Repressive Complex to silence it entirely.

Epigenetics in Development

Epigenetic reprogramming is essential for normal development. When a sperm fertilizes an egg, the paternal genome undergoes rapid demethylation (removing most paternal methylation marks); the maternal genome is demethylated more slowly. After fertilization, the embryo undergoes de novo methylation establishing the epigenetic landscape for each cell lineage.

As cells differentiate, they acquire stable epigenetic states that maintain cell identity. A liver cell remains a liver cell through thousands of divisions because its epigenetic marks reinforce expression of liver-specific genes and silence others — a form of cellular memory encoded not in the DNA sequence itself but in the modifications layered upon it.

Epigenetic Inheritance: Can Experiences Be Inherited?

The concept of transgenerational epigenetic inheritance — the transmission of epigenetic marks (and thus potentially the effects of environmental experiences) across generations — is one of the most debated topics in modern biology.

Evidence in model organisms is strong: in C. elegans (roundworms), RNA-mediated silencing can be maintained for many generations. In mice, males exposed to stress or high-fat diets pass epigenetic alterations to offspring via sperm small RNAs.

In humans, the evidence is more limited but compelling in specific cases. Studies of the Dutch Hunger Winter (1944–45), when Nazi blockades caused famine in the Netherlands, found that children conceived during the famine had altered DNA methylation at specific loci decades later — and that the grandchildren of famine survivors showed measurable health differences. However, confounding factors make interpretation difficult.

The conventional view that the epigenome is largely erased and reset each generation (at fertilization and in primordial germ cells) means wholesale inheritance of acquired epigenetic marks is limited in mammals — but the complete picture is still being worked out.

Epigenetics and Disease

Epigenetic dysregulation underlies numerous diseases:

• Cancer: Virtually all cancers show widespread epigenetic abnormalities — silencing of tumor suppressors, activation of oncogenes, and global hypomethylation. Epigenetic drugs (HDAC inhibitors like vorinostat, DNA demethylating agents like azacitidine) are approved cancer treatments.
• Imprinting disorders: Prader-Willi and Angelman syndromes result from loss of imprinted gene expression (where only the maternal or paternal copy is expressed) due to epigenetic abnormalities at chromosome 15q11-13.
• Aging: DNA methylation changes in a highly predictable pattern with age — so reliably that "epigenetic clocks" (Horvath clock, PhenoAge) can estimate biological age from blood methylation data with high accuracy, providing a biomarker of aging independent of chronological age.
• Neuropsychiatric disorders: Schizophrenia, depression, and PTSD show epigenetic alterations in stress-response gene promoters. Childhood trauma produces lasting epigenetic changes in glucocorticoid receptor gene (NR3C1) methylation.